These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2389 related items for PubMed ID: 26637371

  • 1. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K, Uemura K, Asada M, Maesako M, Akiyama H, Shimohama S, Takahashi R, Kinoshita A.
    Mol Brain; 2015 Dec 04; 8(1):82. PubMed ID: 26637371
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
    Park H, Kam TI, Kim Y, Choi H, Gwon Y, Kim C, Koh JY, Jung YK.
    Hum Mol Genet; 2012 Jun 15; 21(12):2725-37. PubMed ID: 22419736
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M.
    J Neurochem; 2011 Dec 15; 119(6):1330-40. PubMed ID: 21992552
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L, Magnaudeix A, Esclaire F, Yardin C, Terro F.
    Brain Res; 2009 Feb 03; 1252():66-75. PubMed ID: 19071093
    [Abstract] [Full Text] [Related]

  • 9. Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation.
    Hoppe JB, Frozza RL, Horn AP, Comiran RA, Bernardi A, Campos MM, Battastini AMO, Salbego C.
    J Pineal Res; 2010 Apr 03; 48(3):230-238. PubMed ID: 20136701
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway.
    Huang HC, Tang D, Xu K, Jiang ZF.
    J Recept Signal Transduct Res; 2014 Feb 03; 34(1):26-37. PubMed ID: 24188406
    [Abstract] [Full Text] [Related]

  • 12. Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β.
    Amin J, Paquet C, Baker A, Asuni AA, Love S, Holmes C, Hugon J, Nicoll JA, Boche D.
    Neuropathol Appl Neurobiol; 2015 Jun 03; 41(4):445-57. PubMed ID: 25486988
    [Abstract] [Full Text] [Related]

  • 13. Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.
    DaRocha-Souto B, Coma M, Pérez-Nievas BG, Scotton TC, Siao M, Sánchez-Ferrer P, Hashimoto T, Fan Z, Hudry E, Barroeta I, Serenó L, Rodríguez M, Sánchez MB, Hyman BT, Gómez-Isla T.
    Neurobiol Dis; 2012 Jan 03; 45(1):425-37. PubMed ID: 21945540
    [Abstract] [Full Text] [Related]

  • 14. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
    Folwell J, Cowan CM, Ubhi KK, Shiabh H, Newman TA, Shepherd D, Mudher A.
    Exp Neurol; 2010 Jun 03; 223(2):401-9. PubMed ID: 19782075
    [Abstract] [Full Text] [Related]

  • 15. Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease.
    Lloret A, Badia MC, Giraldo E, Ermak G, Alonso MD, Pallardó FV, Davies KJ, Viña J.
    J Alzheimers Dis; 2011 Jun 03; 27(4):701-9. PubMed ID: 21876249
    [Abstract] [Full Text] [Related]

  • 16. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
    Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M, Ishiguro K, Yamaguchi H.
    Neurosci Res; 1998 Aug 03; 31(4):317-23. PubMed ID: 9809590
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z, Zhao R, Qi J, Wen S, Tang Y, Wang D.
    J Neurosci Res; 2011 Mar 03; 89(3):437-47. PubMed ID: 21259330
    [Abstract] [Full Text] [Related]

  • 18. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576.
    Chauhan NB, Siegel GJ, Feinstein DL.
    Neuropharmacology; 2005 Jan 03; 48(1):93-104. PubMed ID: 15617731
    [Abstract] [Full Text] [Related]

  • 19. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo.
    Kim HG, Park G, Lim S, Park H, Choi JG, Jeong HU, Kang MS, Lee MK, Oh MS.
    J Ethnopharmacol; 2015 Aug 02; 171():196-204. PubMed ID: 26068423
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL, Bjorkdahl C, Liu R, Cowburn RF, Winblad B, Pei JJ.
    J Neurochem; 2005 Mar 02; 92(5):1104-15. PubMed ID: 15715661
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 120.